18 Nov 2020 | All | Samsung Bioepis, Biogen | Samsung Bioepis and Biogen announce the FDA has accepted for review the BLA for SB11 (proposed ranibizumab biosimilar).

12 Nov 2020 | All | Samsung Bioepis | Samsung Bioepis announces one-year results from Ph III study of SB...

Please reload

Biosimilars bulletin 

November 9, 2020

Please reload

Search by tags